Van beleggers
voor beleggers
desktop iconMarkt Monitor
  • Word abonnee
  • Inloggen

    Inloggen

    • Geen account? Registreren

    Wachtwoord vergeten?

Ontvang nu dagelijks onze kooptips!

word abonnee

Probiodrug

5 Posts
| Omlaag ↓
  1. Cor54 9 januari 2015 11:46
    Het is de laatste weken erg stil rond dit aandeel. Ik kan ook geen financiele agenda vinden op de website van Probiodrug.
    Na €22,5 miljoen opgehaald te hebben in oktober vorig jaar had ik wel iets meer verwacht. Na een aanvankelijke stijging daalt de koers langzaam maar zeker.
    Wat denken jullie hiervan.
  2. forum rang 10 DeZwarteRidder 10 november 2016 16:06
    ProMIS Neurosciences initiates Cohort Study
    Stockhouse Editorial

    ProMIS Neurosciences Inc (TSX: PMN, OTCQB: ARFXF, Forum) announced today that it has commenced a groundbreaking Cohort Study intended to evaluate the prevalence of different strains of Amyloid beta (Ab)prions in patients with Alzheimer’s disease (AD). First results are anticipated in the first quarter of 2017.

    The Study is being conducted in the laboratories of the Company’s CSO, Dr. Neil Cashman. The study will employ cerebrospinal fluid samples of more than 100 patients with dementia, collected over an eight-year period by Dr. Robin Hsuing, Associate Professor of Neurology at the University of British Columbia. The date accompanying these samples may also lead to the identification of prion strains which are associated with more rapid disease progression. Further information can be found here.

    ProMIS was recently in the news earlier this month when it announced five “novel” antibody targets which met the ideal target profile for Alzheimer’s disease.

    The Company has 181 million shares outstanding and a market cap of $25.4 million.

    Read more at www.stockhouse.com/news/newswire/2016...
5 Posts
|Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord.

Direct naar Forum

Indices

AEX 891,13 +0,42%
EUR/USD 1,0776 +0,11%
FTSE 100 8.213,49 +0,51%
Germany40^ 18.176,40 +0,97%
Gold spot 2.326,65 +1,08%
NY-Nasdaq Composite 16.156,33 +1,99%

Stijgers

Avantium
+3,70%
NSI
+3,67%
SBM Of...
+2,87%
TKH
+2,75%
Aegon
+2,04%

Dalers

NX FIL...
-4,34%
PostNL
-3,86%
Flow T...
-1,96%
DSM FI...
-1,53%
SIGNIF...
-1,44%

Lees verder op het IEX netwerk Let op: Artikelen linken naar andere sites

Gesponsorde links